Cargando…
Recruitment of CD103(+) dendritic cells via tumor-targeted chemokine delivery enhances efficacy of checkpoint inhibitor immunotherapy
Although a clinical breakthrough for cancer treatment, it remains that a minority of patients respond to checkpoint inhibitor (CPI) immunotherapy. The composition of tumor-infiltrating immune cells has been identified as a key factor influencing CPI therapy success. Thus, enhancing tumor immune cell...
Autores principales: | Williford, John-Michael, Ishihara, Jun, Ishihara, Ako, Mansurov, Aslan, Hosseinchi, Peyman, Marchell, Tiffany M., Potin, Lambert, Swartz, Melody A., Hubbell, Jeffrey A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6905870/ https://www.ncbi.nlm.nih.gov/pubmed/31844672 http://dx.doi.org/10.1126/sciadv.aay1357 |
Ejemplares similares
-
Engineered collagen-binding serum albumin as a drug conjugate carrier for cancer therapy
por: Sasaki, Koichi, et al.
Publicado: (2019) -
Targeting inflammatory sites through collagen affinity enhances the therapeutic efficacy of anti-inflammatory antibodies
por: Katsumata, Kiyomitsu, et al.
Publicado: (2019) -
Tumor Cell-Surface
Binding of Immune Stimulating Polymeric
Glyco-Adjuvant via Cysteine-Reactive Pyridyl Disulfide Promotes Antitumor
Immunity
por: Slezak, Anna J., et al.
Publicado: (2022) -
Topically-applied collagen-binding serum albumin-fused interleukin-4 modulates wound microenvironment in non-healing wounds
por: Lauterbach, Abigail L., et al.
Publicado: (2023) -
Author Correction: Topically-applied collagen-binding serum albumin-fused interleukin-4 modulates wound microenvironment in non-healing wounds
por: Lauterbach, Abigail L., et al.
Publicado: (2023)